Ivermectin Highlighted for Early Prevention and Treatment of COVID-19

A health worker shows a bottle of ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Paediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. Luis Robayo/AFP via Getty Images

Doctors at a recent Senate hearing stressed the importance of more research and guidance on the early or preventative treatment of COVID-19 in the fight against the CCP virus, even after the roll-out of vaccines.

The Senate Homeland Security and Governmental Affairs Committee, led by Sen. Ron Johnson (R-Wis.), held a second hearing on early outpatient treatment for COVID-19 on Dec. 8 to “discuss early treatment options that attack the disease in the first stage by limiting viral replication” in hopes of preventing disease progression, hospitalizations, and deaths.